|
USP14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.02349994724716E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61340000004451E-06 |
| Normal-vs-Stage2 |
1.020210E-02 |
| Normal-vs-Stage3 |
1.71140002169778E-09 |
| Normal-vs-Stage4 |
2.42419999996191E-06 |
| Stage1-vs-Stage2 |
7.503000E-01 |
| Stage1-vs-Stage3 |
1.085840E-02 |
| Stage1-vs-Stage4 |
2.236400E-01 |
| Stage2-vs-Stage3 |
9.716000E-02 |
| Stage2-vs-Stage4 |
2.789800E-01 |
| Stage3-vs-Stage4 |
4.854400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.79300000402449E-08 |
| Normal-vs-AfricanAmerican |
3.6802000003E-07 |
| Normal-vs-Asian |
1.131980E-01 |
| Caucasian-vs-AfricanAmerican |
2.359400E-01 |
| Caucasian-vs-Asian |
7.053600E-01 |
| AfricanAmerican-vs-Asian |
3.927200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.25850002536043E-09 |
| Normal-vs-Female |
3.3803000000221E-06 |
| Male-vs-Female |
1.799990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.843130E-04 |
| Normal-vs-Age(41-60Yrs) |
2.31859999999529E-06 |
| Normal-vs-Age(61-80Yrs) |
1.23900000259525E-08 |
| Normal-vs-Age(81-100Yrs) |
1.992480E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.090400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.571200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.542400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.720020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.971000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.117200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.395900E-02 |
| Normal-vs-Grade 2 |
3.66630000000479E-05 |
| Normal-vs-Grade 3 |
1.73400005465396E-09 |
| Normal-vs-Grade 4 |
1.79119999943467E-08 |
| Grade 1-vs-Grade 2 |
8.364200E-01 |
| Grade 1-vs-Grade 3 |
2.422000E-01 |
| Grade 1-vs-Grade 4 |
1.373960E-01 |
| Grade 2-vs-Grade 3 |
1.436070E-02 |
| Grade 2-vs-Grade 4 |
6.963600E-03 |
| Grade 3-vs-Grade 4 |
2.421200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.185300E-04 |
| Normal-vs-ccB subtype |
3.24619999991782E-07 |
| ccA subtype-vs-ccB subtype |
1.322580E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.62619999968905E-07 |
| Normal-vs-N1 |
3.390400E-01 |
| N0-vs-N1 |
5.880000E-01 |
|
|
